4/A: Aeluma CEO Sells 150,000 Shares, Amends Filing

Aeluma, Inc. CEO Jonathan Klamkin sold 150,000 shares of common stock and amended a previous filing to clarify the nature of the transaction.

Summary

• CEO Jonathan Klamkin, also a Director and 10% Owner of Aeluma, Inc. (ALMU), reported several transactions in the company's securities.
• On July 1, 2025, Klamkin acquired 2,403 shares of common stock through restricted stock units (RSUs) and stock options for 6,253 shares, both granted as an immediately vested bonus approved by the Issuer's Board of Directors.
• On August 14, 2025, Klamkin disposed of 150,000 shares of Aeluma, Inc. common stock at a weighted average sale price of $18.8487 per share.
• This Form 4/A amends the original filing from August 14, 2025, specifically to remove and correct the reference to a Rule 10b5-1 trading plan, clarifying that the shares were sold pursuant to a 'non-10b5-1 trading arrangement' which has since been terminated.
• Following these reported transactions, Klamkin directly beneficially owns 1,479,398 shares of common stock and 326,253 stock options.

Sentiment

Score: 4

Explanation: The significant insider sale by the CEO, coupled with the amendment correcting the nature of the trading plan, generally indicates a negative sentiment. While a bonus was received, the sale overshadows it from an investor perspective.

Positives

• CEO Jonathan Klamkin received a bonus of 2,403 shares of common stock (via RSUs) and 6,253 stock options, indicating board confidence or performance recognition.
• The bonus RSUs and stock options vested immediately, providing immediate ownership and incentive to the CEO.

Negatives

• CEO Jonathan Klamkin sold a significant number of shares (150,000), which could be interpreted negatively by the market as a signal of reduced confidence.
• The amendment indicates an initial error in reporting the nature of the trading plan (incorrectly referencing a Rule 10b5-1 plan), which could raise questions about the accuracy of initial disclosures and internal compliance.

Risks

• Insider selling by a CEO and 10% owner, especially of a substantial amount, could signal a lack of confidence in the company's future stock performance, potentially impacting investor sentiment negatively.
• The correction regarding the 10b5-1 plan might draw scrutiny from regulatory bodies or investors regarding the accuracy and timeliness of initial disclosures.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding the company's future performance or strategic direction, as it primarily reports insider transactions.

Management Comments

• "The RSUs and the Stock Options were granted to the Reporting Person as a bonus and vested immediately (the 'Bonus'). The Bonus was approved by the Issuer's Board of Directors."
• "This amendment is being filed solely to remove and correct the reference to a Rule 10b5-1 trading plan and uncheck the box on the cover page relating to same. The shares were sold pursuant to a 'non-10b5-1 trading arrangement,' as defined in Item 408(c) of Regulation S-K of the Exchange Act and has been terminated."

Industry Context

This Form 4/A filing is specific to insider trading activity and does not provide broader industry context or trends. Insider sales can sometimes be viewed as a signal by the market, but without additional context, it's difficult to draw conclusions about industry-wide implications.

Comparison to Industry Standards

• This filing reports insider transactions and does not contain information suitable for comparison to industry-specific operational or financial benchmarks.
• The nature of the transactions (bonus, sale) is standard for executive compensation and personal portfolio management. However, the scale of the sale by a CEO could be noteworthy depending on the company's market capitalization and typical insider activity for comparable firms in the technology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the CEO's significant share sale negatively, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Regulatory Authorities: The amendment regarding the 10b5-1 plan might draw attention from the SEC regarding disclosure accuracy.

Next Steps

• Investors will likely monitor future insider trading activity by Jonathan Klamkin and other Aeluma, Inc. executives.
• The market will likely observe Aeluma, Inc.'s stock performance for any reaction to this insider sale.

Key Dates

Recommendation

The significant sale of 150,000 shares by CEO Jonathan Klamkin, a 10% owner, is a notable negative signal that could impact investor sentiment. While the CEO also received a bonus of RSUs and options, the scale of the sale is more impactful. The amendment correcting the nature of the trading plan also adds a layer of scrutiny. However, without additional financial performance data or strategic updates from Aeluma, Inc., a 'hold' recommendation is prudent to observe market reaction and await further company disclosures before making a more definitive 'buy' or 'sell' decision. Investors should monitor future insider activity and company news closely.

Keywords

Aeluma Inc., ALMU, Jonathan Klamkin, Insider Trading, Form 4/A, Stock Sale, CEO, Restricted Stock Units, Stock Options, Beneficial Ownership